| Literature DB >> 35604044 |
Hubert A Benzon1, Anthony Tantoco1, Anthony Longhini2, John Hajduk1, Amanda Saratsis3, Santhanam Suresh1, Robert J McCarthy4, Narasimhan Jagannathan1.
Abstract
INTRODUCTION: Posterior fossa decompression for Chiari I Malformation is a common pediatric neurosurgical procedure. We sought to identify the impact of anesthesia-related intraoperative complications on unanticipated admission to the intensive care unit and outcomes following posterior fossa decompression.Entities:
Keywords: child; complications; general anesthesia; neurosurgery
Mesh:
Year: 2022 PMID: 35604044 PMCID: PMC9541405 DOI: 10.1111/pan.14496
Source DB: PubMed Journal: Paediatr Anaesth ISSN: 1155-5645 Impact factor: 2.129
Clinical characteristics, intraoperative anesthesia complications, surgical factor, and year of surgery in subjects with and without an unanticipated intensive care unit admission following posterior fossa decompression surgery for Chiari I Malformation
| Unanticipated intensive care unit admission |
| Effect size (95% Confidence interval) | ||
|---|---|---|---|---|
| No ( | Yes ( | |||
| Age (y) | 10 (5–14) | 3 (1–7.5) | .016 | 1.08 (0.19–1.97) |
| BMI (kg/m2) | 18.7 (15.5–22.3) | 18.6 (15.4–29.6) | .972 | −0.14 (−1.03–0.73) |
| Sex | ||||
| Female | 177 (61) | 4 (80) | .652 | 0.19 (−0.20 to 0.53) |
| Male | 114 (39) | 1 (20) | ||
| ASA physical status | ||||
| 1 or 2 | 226 (78) | 0 (0) | <.001 | −0.77 (−0.82 to −0.72) |
| 3 or 4 | 65 (22) | 5 (100) | ||
| Presenting symptom | ||||
| Incidental | 21 (7) | 1 (20) | .144 | −0.18 (−0.67 to 0.42) |
| Neurological | 181 (62) | 1 (20) | ||
| Comorbidity | 89 (31) | 3 (60) | ||
| Cervical spine instability | 5 (2) | 0 (0) | .804 | 0.02 (0.00–0.03) |
| Syndrome | 17 (6) | 0 (0) | .613 | 0.06 (0.03–0.08) |
| Previous decompression surgery | 24 (8) | 1 (20) | .356 | −0.11 (−0.46 to 0.26) |
| Size of malformation (mm) | 10 (7–15) | 11.5 (6–26) | .684 | −0.59 (−1.58 to 0.40) |
| Concomitant syringomyelia | 168 (57) | 1 (20) | .168 | 0.38 (−0.05 to 0.69) |
| Dura entered | 189 (65) | 3 (60) | .818 | 0.04 (−0.39 to 0.47) |
| Duration of surgery (min) | 189 (149–225) | 129 (98–308) | .719 | −0.01 (−0.89 to 0.88) |
| Intraoperative complication | ||||
| No | 268 (92) | 3 (60) | .010 | −0.32 (−0.69 to 0.18) |
| Yes | 23 (8) | 2 (40) | ||
| Intraoperative complication count by type | ||||
| Bradycardia | 3 | 0 | .819 | 0.01 (−0.00 to 0.02) |
| Hypertension | 2 | 0 | .852 | 0.00 (−0.0 to 0.01) |
| Hypotension | 3 | 1 | .066 | −0.19 (−0.52 to 0.20) |
| Arrythmia | 0 | 0 | ‐‐ | ‐‐ |
| Aspiration | 0 | 0 | ‐‐ | ‐‐ |
| Transfusion | 2 | 0 | .852 | 0.01 (−0.00 to 0.02) |
| Hypoxemia | 0 | 0 | ‐‐ | ‐‐ |
| Oversedation | 6 | 0 | .746 | 0.02 (0.00–0.03) |
| Loss of Neuromonitoring Signals | 3 | 1 | .066 | −0.19 (−0.52 to 0.20) |
| Airway Adjustment | 6 | 0 | .746 | 0.02 (0.00–0.04) |
| Unanticipated Extubation | 1 | 0 | .896 | 0.00 (−0.00 to 0.01) |
| Possible Venous Air Embolism | 0 | 1 | .017 | −0.2 (−0.38 to −0.01) |
| Year of surgery | ||||
| 2009–2010 | 42 (14) | 1 (20) | .877 | 0.41 (0.04–0.68) |
| 2011–2012 | 43 (15) | 1 (20) | ||
| 2013–2014 | 49 (17) | 2 (40) | ||
| 2015–2016 | 61 (21) | 1 (20) | ||
| 2017–2018 | 59 (20) | 0 (0) | ||
| 2019–2021 | 37 (13) | 0 (0) | ||
Note: Data presented as median (1st–3rd quartile) or n (% of column). Effect size reported as Hedges g for continuous data or Cliff's Delta for nominal or ordinal data.
Abbreviations: ASA, American society of anesthesiologists; BMI, body mass index.
Syndromes included neurofibromatosis 1, Xia‐Gibbs syndrome, Goldenhar, DiGeorge, Mucopolysaccharidosis type 4 (Morquio), Pfeiffer Syndrome.
Number with reported malformation size (n = 204).
Anesthesia factors associated with an intraoperative anesthesia‐related complication during posterior fossa decompression surgery for Chiari I Malformation
| Intraoperative anesthetic‐related complication |
| Effect size (95% Confidence interval) | ||
|---|---|---|---|---|
| No ( | Yes ( | |||
| Induction type | ||||
| Inhalational | 185 (68) | 16 (64) | .659 | 0.09 (−0.32 to 0.50) |
| Intravenous | 86 (32) | 9 (36) | ||
| Maintenance inhalational agent | ||||
| Sevoflurane | 250 (92) | 20 (80) | .027 | −0.11 (−0.27 to 0.04) |
| Isoflurane | 16 (6) | 5 (20) | ||
| Sevoflurane / Isoflurane combined | 5 (2) | 0 (0) | ||
| Nitrous Oxide | 9 (3) | 4 (16) | .017 | −0.13 (−0.27 to 0.02) |
| Local anesthetic | ||||
| None | 131 (48) | 8 (32) | .219 | −0.19 (−0.39 to 0.03) |
| Per anesthesia | 53 (20) | 5 (32) | ||
| Per Surgery | 87 (32) | 12 (48) | ||
| Neuromuscular blockade | 256 (94) | 25 (100) | .625 | −0.05 (−0.08 to −0.03) |
| Opioids | ||||
| Any | 266 (98) | 25 (100) | .493 | 0.13 (−0.04 to 0.29) |
| Fentanyl bolus | 198 (73) | 22 (88) | .149 | −0.14 (−0.28 to 0.00) |
| Fentanyl infusion | 65 (24) | 6 (24) | .999 | −0.00 (−0.17 to 0.17) |
| Remifentanil infusion | 38 (14) | 2 (8) | .549 | 0.06 (−0.05 to 0.17) |
| Dexmedetomidine infusion | 42 (16) | 5 (20) | .581 | −0.04 (−0.02 to 0.12) |
| Propofol infusion | 44 (16) | 3 (12) | .327 | 0.04 (−0.09 to 0.17) |
| Intraoperative fluids (mls/kg/hr) | 10 (7–14) | 11 (8–14) | .340 | −0.08 (−0.48 to 0.33) |
| Estimated blood loss (ml) | 25 (10–50) | 20 (10–50) | .233 | 0.20 (−0.20 to 0.61) |
| Arterial line | 87 (32) | 11 (44) | .268 | −0.11 (−0.31 to 0.09) |
Note: Data presented as median (1st–3rd quartile) or n (% of column). Effect size reported as Hedges g for continuous data or Cliff's Delta for nominal or ordinal data.
Number with recorded estimate blood loss (n = 274).
Firth's bias reduction logistic regression model for an unanticipated intensive care unit admission
| Variable |
| Odds ratio | 95% Confidence intervals |
|
|---|---|---|---|---|
| Age (years) | −.10 | 0.89 | 0.69–1.13 | .357 |
| Male sex | −.48 | 0.62 | 0.04–4.42 | .641 |
| Body mass index | .04 | 1.04 | 0.96–1.12 | .189 |
| ASA physical status >2 | 2.15 | 8.60 | 0.99–1010 | .050 |
| Presenting symptom | ||||
| Incidental | 1 | ‐‐ | ||
| Neurological | −1.68 | 0.18 | 0.00–4.72 | .291 |
| Clinical comorbidity | −.31 | 0.73 | 0.06–12.50 | .806 |
| Concomitant syringomyelia | −.56 | 0.58 | 0.04–5.85 | .626 |
| Intraoperative complication | 1.77 | 5.87 | 0.51–59.63 | .149 |
| Previous decompression surgery | .11 | 1.11 | 0.06–10.91 | .930 |
| Year of Surgery | ||||
| 2009–2015 | 1 | |||
| 2016–2021 | −1.56 | 0.21 | 0.00–1.95 | .190 |
| Intercept | −3.34 | .020 |
Postoperative complications and surgical outcomes
| Unanticipated intensive care unit admission | Difference (95% Confidence interval) |
| ||
|---|---|---|---|---|
| No | Yes | |||
|
|
| |||
| Postoperative complications | ||||
| Nausea/vomiting | 37 (13) | 1 (20) | 8 (−49 to 35) | .499 |
| Uncontrolled pain | 6 (2) | 0 (0) | 2 (−6 to 27) | .746 |
| Apnea requiring oxygen therapy | 5 (2) | 1 (20) | −18 (−6 to 27) | .167 |
| Blood transfusion for anemia | 4 (1) | 0 (0) | 1 (−43 to 26) | .724 |
| Infection | 4 (1) | 0 (0) | 1 (−43 to 26) | .792 |
| Upper airway obstruction | 1 (1) | 2 (40) | −39 (−93 to −26) | .002 |
| Pneumonia | 1 (1) | 0 (0) | 1 (−45 to 26) | .861 |
| Surgical Outcomes | ||||
| Neurological improvement | ||||
| Yes | 260 (90) | 4 (80) | 10 (−35 to 54) | |
| No | 19 (6) | 1 (20) | −14 (−59 to 32) | .670 |
| Lost to follow‐up | 3 (1) | 0 (0) | 1 (−44 to 26) | |
| No preoperative deficit | 8 (3) | 0 (0) | 3 (−40 to 26) | |
| New or worsening neurological deficit | ||||
| No | 273 (94) | 5 (100) | −6 (−15 to 3) | |
| Yes | 16 (5) | 0 (0) | 5 (−35 to 26) | .850 |
| Recurrence of old symptoms | 2 (1) | 0 (0) | 1 (−44 to 26) | |
| Complete syrinx resolution | ||||
| Yes | 29 (17) | 1 (100) | −83 (−100 to 59) | |
| No | 111 (66) | 0 (0) | 66 (18–93) | .206 |
| Lost to follow‐up | 28 (27) | 0 (0) | 27 (−26 to 39) | |
| Pseudomeningocele | 22 (8) | 1 (20) | −12 (−57 to 33) | .335 |
| Aseptic meningitis | 6 (2) | 0 (0) | 2 (−42 to 26) | .760 |
| Cerebrospinal fluid leak | 8 (3) | 0 (0) | 3 (−40 to 26) | .637 |
| New‐onset hydrocephalus | 8 (3) | 0 (0) | 3 (−40 to 26) | .707 |
| Epidural or subdural hematoma | 3 (1) | 0 (0) | 1 (−44 to 26) | .819 |
| Wound infection | 5 (1) | 0 (0) | 1 (−10 to 13) | .726 |
| Emergency room visit within 7 days of surgery | 27 (9) | 2 (40) | −31 (−83 to 22) | .077 |
| Readmission within 30 days | 33 (11) | 1 (20) | −9 (−52 to 35) | .459 |
Note: Data reported as n (% of column). Differences reported as percent difference and 95% confidence intervals.